ArticleJAAD case reports2025

Recurrence of mogamulizumab-associated rash in patients with relapsed erythrodermic cutaneous T-cell lymphoma after retreatment with mogamulizumab.

Emma R McIntyre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.